Trials / Completed
CompletedNCT00653003
Bioavailability Study of Leflunomide Tablets Under Fed Conditions
To Compare the Relative Bioavailability of Leflunomide 20mg Tablets (Kali) With That of ARAVA 20mg Tablets(Aventis) Under Fed Conditions
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 62 (actual)
- Sponsor
- Par Pharmaceutical, Inc. · Industry
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
To compare the single-dose Bioavailability of Kali and Aventis
Detailed description
To compare the relative Bioavailability of leflunomide 20mg tablets with that of ARAVA 20mg tablets in healthy female subjects under fed conditions
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Leflunomide | tablets, 20mg, single-dose |
| DRUG | ARAVA | Tablets, 20mg, single-dose |
Timeline
- Start date
- 2003-12-01
- Primary completion
- 2004-01-01
- Completion
- 2004-01-01
- First posted
- 2008-04-04
- Last updated
- 2017-09-26
Source: ClinicalTrials.gov record NCT00653003. Inclusion in this directory is not an endorsement.